Biotech stocks are booming, but resistance looms close. Time to take profits on the SPDR S&P Biotech (ETF) XBI calls, but also consider reloading. More
AMGN
Recent Articles
5 Biotech Stocks That Are Roaring Back to Life
These biotech stocks are making their way past recent lows based on a potential pause in focus and action by Trump. More
3 Biotech Trades to Diversify Your Portfolio
There’s always a bull market somewhere. At times, there are bulls and bears in the same sector, as is the case with these biotech stocks. More
Is Teva Pharmaceutical Industries Ltd (ADR) Stock a Migraine Buy?
Teva's recent migraine drug data, while positive, didn't impress investors. What happened, and should you tussle with TEVA stock? More
Stocks Climb During Trump’s First International Visit
In the end, the Dow Jones gained 0.4%, the S&P 500 gained 0.5%, the Nasdaq gained 0.8% and the Russell 2000 added 0.7%. More
Why Amgen, Inc. (AMGN), Advanced Micro Devices, Inc. (AMD) and Forterra Inc (FRTA) Are 3 of Today’s Worst Stocks
Forterra (FRTA), Advanced Micro Devices (AMD) and Amgen (AMGN) shareholders ended up wishing last weekend was a three-day break. More
3 Big Stock Charts for Monday: Bristol-Myers Squibb Co (BMY), Pfizer Inc. (PFE) and Amgen, Inc. (AMGN)
Bristol-Myers Squibb (BMY), Pfizer (PFE) and Amgen (AMGN) are teasing the technical traders as their charts suggest the potential for a short-term buying opportunity. More
